Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
| Image |  |
|---|---|
| Description | journal article from 'Prostate Cancer and Prostatic Diseases' published in 2022 |
| Author/s |
author: Fred Saad |
| Publication date | June 2022 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |